Risk of Diabetes and Renal Dysfunctions in Postmenopausal Women using AntidepressantsforShort Term
DOI:
https://doi.org/10.51273/esc23.251319310Keywords:
Urea, Creatinine, Anti-depressant, post-menopausalAbstract
Objective: To study the use of antidepressants for a short period and the risk of diabetes and kidney functions in postmenopausal women of Peshawar city Khyber Pakhtunkhwa.
Material and Methods: The patient group (PG) consisted of 140 postmenopausal women taking various antidepressants drugs for ≥3 and <6 months, and 140 postmenopausal women from the Khyber Pakhtunkhwa general population as controls. Serum urea was measured using the UV kinetic method, serum creatinine was measured using the modified Jaffe method, and glycated hemoglobin (HbA1c) was measured using the rapid ion-exchange resin separation method.
Results: Mean age was 51.65 ± 5.81 years in the control group (CG), 43.09 ± 6.28 years in the selective serotonin reuptake inhibitor (SSRI) group, and 45.33 ± 5.15 years in the PG tricyclic antidepressant (TCA) 2group. Mean BMI for the CG, SSRI, and TCAgroups was 25.42 ± 5.04, 30.49 ± 7.25, and 28.71 ± 7.78 kg/m , respectively. Mean serum urea in the CG, SSRI and TCAgroups was 27.07 ± 7.78, 30.17 ± 30.39 and 21.40 ± 3.56 mg/dl, respectively. Mean serum creatinine in the CG, SSRI and TCAgroups was 0.85 ± 0.21, 0.70±0.28
and 0.67±0.09 mg/dl, respectively. Mean HbA1c in the CG, SSRI, and TCA groups were 6.06±0.59, 5.67±0.56, and 5.45 ± 0.49%, respectively. Mean fasting blood glucose levels in the CG, SSRI, and TCA groups was 85.37 ± 8.34, 79.96 ± 7.85, and 76.96 ± 7.04 mg/ld., respectively.
Conclusion: The result of this study showed that short term use of SSRIs, and TCAs may lower the risk of diabetes and renal dysfunctions in postmenopausal women
References
http://www.rxlist.com/script/main/art.asp?articlekey=88888#tocb.(accessed on 2 March 2023)
http://www.mayoclinic.org/diseases-conditions/depression/in-depth/ antidepressants/art-20046273(accessed on 2 March 2023).
Jhansi K, Vanita P, Lavanya S, Satya V. A Review on Antidepressant Drugs. Adv. Pharmacoepidemiol Drug Saf. 2014; 3(1):1-2.
Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Journal of affective disorders. 2000 Apr 1; 58(1):19-36.
Mojtabai R. Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychotherapy and psychosomatics. 2008; 77(2):83-92...
Ma Y, Balasubramanian R, Pagoto SL, Schneider KL, Culver AL, Olendzki B, Tinker L, Liu S, Safford M, Sepavich DM, Rosal MC. Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women. Diabetes Care. 2011 Nov 1; 34(11):2390-2...
Andersohn F, Schade R, Suissa S, Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. American Journal of Psychiatry. 2009 May; 166(5):591-8.
Mindell J, Biddulph JP, Hirani V, Stamatakis E, Craig R, Nunn S, Shelton N. Cohort profile: the health survey for England. International journal of epidemiology. 2012 Dec 1; 41(6):1585-93.
. Kivimäki M, Batty GD. Antidepressant drug use and future diabetes risk. Diabetologia. 2012 Jan 1; 55(1):10-2.
Rej S, Herrmann N, Shulman K. The effects of lithium on renal function in older adults—a systematic review. Journal of geriatric psychiatry and neurology. 2012 Mar; 25(1):51-61.
Tietz NW. Fundamentals of clinical Chemistry, 3rd. Edition (1987); 676-679, W.B. Saunders Company Philadelphia.
Nuttal F.Q. Diabetes care 1998; 21:1475-1480.
Khalily MT. Developing an integrated approach to the mental health issues in Pakistan. Journal of Interprofessional Care2010; 24(2):168–72.
Gadit AA, Vahidy A. Mental health morbidity pattern in Pakistan. Journal of College of Physicians and Surgeons Pakistan. 1999;9:362-5
Kessler RC, Angermeyer M, Anthony JC, de Graaf R, Demyttenaere K, Gasquet I, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007; (6):168-76.
Murray CJ, Lopez AD. Evidence-based health policy — lessons from the global burden of disease study. Science 1996; (274):740-3.
Dodani S, Zuberi RW. Center-based prevalence of anxiety and depression in women of the northern areas of Pakistan. J Pak Med Assoc 2000; (50):138-40.
Rasheed S, Khan MA, Khan B, Khan MY. Depression in medical in-patients. Pak Armed Forces Med J 2003; (53):132-5.
Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep 2007; (9):449-59.
Ma Y, Balasubramanian R, Pagoto SL, Schneider KL, Culver AL, Olendzki B, Tinker L, Liu S, Safford M, Sepavich DM, Rosalie MC, Ockene JK, Carnethon M, Zorn M, Hebert JR. Elevated depressive symptoms, antidepressant use, and diabetes in a large multi-ethnic national sample of postmenopausal women. Diabetes Care 2011; (34):2390–2392.
Lustman PJ, Clouse RE, Nix BD, et al: Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo controlled trial. Arch Gen Psychiatry 2006 May; 63(5): ss. 521-9.
Pyykkonen AJ, Raikkonen K, Tuomi T, Eriksson JG, Groop L, Isomaa B. Depressive symptoms, antidepressant medication use, and insulin resistance: the PPP-Botnia Study. Diabetes Care 2011; (34):2545–2547.
Andersohn F, Schade R, Suissa S, Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry 2009; (166):591- 598.
Moore M, Yuen HM, Dunn N, Mullee MA, Maskell J, Kendrick T. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. Bmj. 2009 Oct 15; 339:b3999.
Van Wyck Fleet J, Manberg PJ, Miller LL, et al. Overview of clinically significant adverse reactions to bupropion. J Clin Psychiatry 1983; (44):191–6.
